Attune Pharmaceuticals Overview

  • Founded
  • 2018
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $23.3M
Latest Deal Amount
  • Investors
  • 7

Attune Pharmaceuticals General Information

Description

Developer of orally-administered small molecule therapeutics intended for the treatment of rare diseases. The company develops therapeutics, heterocyclic derivative compounds, and pharmaceutical compositions used to cure hereditary angioedema and other diseases, enabling clinicians to treat rare medical conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 250 West 55th Street
  • 34th Floor
  • New York, NY 10019
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Attune Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 23-Jan-2019 $23.3M 000.00 00000 Completed Startup
1. Early Stage VC (Series A) 00.000 00.000 000.00 Completed Startup
To view Attune Pharmaceuticals’s complete valuation and funding history, request access »

Attune Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A 0,000,000 00.000000 00 00 00 00 00 00.000
To view Attune Pharmaceuticals’s complete cap table history, request access »

Attune Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of orally-administered small molecule therapeutics intended for the treatment of rare diseases. The company de
Drug Discovery
New York, NY
000.00
0000 0000-00-00
00000000000 000.00

0000000

derit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupida
0000 000000000
San Diego, CA
00 As of 0000
000.00
0000 0000-00-00
00000000000 000.00

000000 0

itation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehende
0000 000000000
Burlingame, CA
00 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Attune Pharmaceuticals Competitors (33)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Epirium Bio Venture Capital-Backed San Diego, CA 00 000.00 00000000000 000.00
000000 00000000000 Formerly VC-backed Burlingame, CA 00 00000 000000 - 000 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
000000000 00000000 Venture Capital-Backed Hennigsdorf, Germany 0 00.000 0000000000 0 00.000
0000 00000000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
You’re viewing 5 of 33 competitors. Get the full list »

Attune Pharmaceuticals Executive Team (3)

Name Title Board Seat Contact Info
Andrew McDonald Ph.D Co-Founder, Chief Executive Officer & Board Member
Jason Bablak JD Chief Operating Officer
Ira Kalfus MD Chief Medical Officer
To view Attune Pharmaceuticals’s complete executive team members history, request access »

Attune Pharmaceuticals Board Members (3)

Name Representing Role Since
Adam Tomasi Ph.D Self Board Member 000 0000
Andrew McDonald Ph.D Attune Pharmaceuticals Co-Founder, Chief Executive Officer & Board Member 000 0000
Roderick Wong MD RTW Investments Board Member 000 0000
To view Attune Pharmaceuticals’s complete board members history, request access »

Attune Pharmaceuticals Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Boxer Capital Venture Capital Minority 000 0000 000000 0
LifeSci Venture Partners Corporate Venture Capital Minority 000 0000 000000 0
RA Capital Management Hedge Fund Minority 000 0000 000000 0
RTW Investments Venture Capital Minority 000 0000 000000 0
Tang Capital Management Corporation Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »